Company / Shareholders' Equity
Avidity Biosciences, Inc. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.7B
FY2025
5-year range
$381.4M / $1.7B
FY2021-FY2025
Trend
+18.5%
vs FY2024
Sector context
#30 of 213
Health Care
What the data says
Avidity Biosciences, Inc.'s shareholders' equity of $1.7B is higher than 86% of companies in the Health Care sector (FY2025). Improved from $501M to $1.7B over the past 2 years.
Based on SEC 10-K filings.
$1.7B in FY2025 with a 5-year CAGR of +40.7%. Top quartile in the Health Care sector.
Improved from $501M to $1.7B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +42.9%
- 5-Year CAGR
- +40.7%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 213This company $1.7B Sector average $2.5B
▼
-33.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +40.7%, indicating consistent growth.
- In FY2025, shareholders' equity increased 18.5% year-over-year.
- Ranks #30 out of 213 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7B | +18.5% |
| FY2024 | $1.4B | +184.6% |
| FY2023 | $500.8M | -13.4% |
| FY2022 | $578.1M | +51.6% |
| FY2021 | $381.4M | +24.6% |
| FY2020 | $306.2M | +568.5% |
| FY2019 | -$65.4M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026